TGFB1 genetic polymorphisms and coronary heart disease risk: a meta-analysis

[1]  S. Ghaderian,et al.  Association of Transforming Growth Factor-&bgr;1 Gene Polymorphisms With Genetic Susceptibility to Acute Myocardial Infarction , 2011, The American journal of the medical sciences.

[2]  Claudio J. Verzilli,et al.  Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration , 2011, European heart journal.

[3]  N. Mehta.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.

[4]  G. Vriend,et al.  Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.

[5]  Mark I. McCarthy,et al.  A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease , 2011, Nature Genetics.

[6]  Scott Mellis,et al.  Transforming Growth Factor-&bgr; Signaling Pathway in Patients With Kawasaki Disease , 2011, Circulation. Cardiovascular genetics.

[7]  S. Leal,et al.  Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections. , 2010, American journal of human genetics.

[8]  L. Palmer,et al.  Association of an allele on chromosome 9 and abdominal aortic aneurysm. , 2010, Atherosclerosis.

[9]  Marie-José Goumans,et al.  Signaling by members of the TGF-beta family in vascular morphogenesis and disease. , 2010, Trends in cell biology.

[10]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[11]  X. Chu,et al.  Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population , 2010, Journal of Human Genetics.

[12]  A. Hata,et al.  Differential Effects of Chromosome 9p21 Variation on Subphenotypes of Intracranial Aneurysm: Site Distribution , 2010, Stroke.

[13]  J. Marchini,et al.  Genotype imputation for genome-wide association studies , 2010, Nature Reviews Genetics.

[14]  Alexander V. Favorov,et al.  Complex analysis of association of inflammation gene polymorphisms with myocardial infarction , 2010, Molecular Biology.

[15]  Alexander V. Favorov,et al.  [Complex analsis of association of inflammation genes with myocardial infarction]. , 2010, Molekuliarnaia biologiia.

[16]  L. Baum,et al.  Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and β3‐adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes—an 8‐year prospective cohort analysis of 1297 patients , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[17]  Alejandro F. Frangi,et al.  Genome-wide association study of intracranial aneurysm identifies three new risk loci , 2010, Nature genetics.

[18]  D. Dichek,et al.  TGF-&bgr;1 Limits Plaque Growth, Stabilizes Plaque Structure, and Prevents Aortic Dilation in Apolipoprotein E–Null Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Dietz,et al.  Circulating Transforming Growth Factor-&bgr; in Marfan Syndrome , 2009, Circulation.

[20]  L. Smeeth,et al.  Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk , 2009, Human molecular genetics.

[21]  G. Mintz,et al.  Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome. , 2009, The American journal of cardiology.

[22]  J. Golledge,et al.  Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion , 2009, European Journal of Human Genetics.

[23]  D. Cokkinos,et al.  Inflammatory cytokine gene variants in coronary artery disease patients in Greece , 2008, Coronary artery disease.

[24]  Praveen Sethupathy,et al.  MicroRNA target site polymorphisms and human disease. , 2008, Trends in genetics : TIG.

[25]  A. Piazza,et al.  Role of TGF-β1 haplotypes in the occurrence of myocardial infarction in young Italian patients , 2008, BMC Medical Genetics.

[26]  H. Stefánsson,et al.  The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm , 2008, Nature Genetics.

[27]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[28]  A. Gylfason,et al.  A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction , 2007, Science.

[29]  A. Agrotis,et al.  Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. , 2007, Cardiovascular research.

[30]  Kanae Oda,et al.  Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. , 2007, Human molecular genetics.

[31]  Jonathan C. Cohen,et al.  A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.

[32]  A. Hofman,et al.  TGF-&bgr;1 Polymorphisms and Risk of Myocardial Infarction and Stroke: The Rotterdam Study , 2006, Stroke.

[33]  A. Kastrati,et al.  Association of Transforming Growth Factor-&bgr;1 Gene Polymorphisms With Myocardial Infarction in Patients With Angiographically Proven Coronary Heart Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[34]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[35]  O. Tokunaga,et al.  Significant Expression of Endoglin (CD105), TGFβ-1 and TGFβ R-2 in the Atherosclerotic Aorta: An Immunohistological Study , 2006 .

[36]  C. Hurley,et al.  Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms , 2006, Human Genetics.

[37]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[38]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. , 2005, American journal of epidemiology.

[39]  S. Shete,et al.  Mutations in Transforming Growth Factor-&bgr; Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections , 2005, Circulation.

[40]  D. Spandidos,et al.  Protein and mRNA expression levels of VEGF-A and TGF-beta1 in different types of human coronary atherosclerotic lesions. , 2005, International journal of molecular medicine.

[41]  J. Erdmann,et al.  Distinct Heritable Patterns of Angiographic Coronary Artery Disease in Families With Myocardial Infarction , 2005, Circulation.

[42]  B. Jaber,et al.  Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. , 2004, Kidney international.

[43]  J. Chang-Claude,et al.  A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer , 2003 .

[44]  R. Siegel,et al.  Coronary remodeling of proximal and distal stenotic atherosclerotic plaques within the same artery by intravascular ultrasound study. , 2001, The American journal of cardiology.

[45]  M. Yokota,et al.  Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. , 2000, Circulation.

[46]  S Duval,et al.  Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.

[47]  V. Sharma,et al.  Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage , 2000 .

[48]  S E Nissen,et al.  Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study. , 2000, Circulation.

[49]  M. Condron,et al.  Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. , 1999, Circulation.

[50]  J. Gunn,et al.  Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. , 1998, Clinical science.

[51]  D. Wilcken,et al.  A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease. , 1998, Clinical science.

[52]  J. Gunn,et al.  Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. , 1998, Clinical science.

[53]  K. Ikeda,et al.  Association of a Polymorphism of the Transforming Growth Factor‐β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  R. Virmani,et al.  Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Arveiler,et al.  Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. , 1996, Hypertension.

[56]  T. Zderic,et al.  βig-h3, a Transforming Growth Factor–β–Inducible Gene, Is Overexpressed in Atherosclerotic and Restenotic Human Vascular Lesions , 1996 .

[57]  T. McCaffrey,et al.  Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. , 1995, The Journal of clinical investigation.

[58]  R. Derynck,et al.  Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Hermiller,et al.  In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. , 1993, The American journal of cardiology.

[60]  J. Isner,et al.  Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. , 1992, The Journal of clinical investigation.

[61]  S. Schwartz,et al.  Production of transforming growth factor beta 1 during repair of arterial injury. , 1991, The Journal of clinical investigation.

[62]  J. Schofer,et al.  Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease. , 1989, Circulation.

[63]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[64]  G. Moneta.  Rare Copy Number Variants Disrupt Genes Regulating Vascular Smooth Muscle Cell Adhesion and Contractility in Sporadic Thoracic Aortic Aneurysms and Dissections , 2011 .

[65]  Yi Wang,et al.  BMC Medical Genetics , 2007 .

[66]  O. Tokunaga,et al.  Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. , 2006, Journal of atherosclerosis and thrombosis.

[67]  J. Chang-Claude,et al.  A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. , 2003, Cancer research.

[68]  M. Suthanthiran,et al.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[69]  T. Spector,et al.  Genetic control of the circulating concentration of transforming growth factor type beta1. , 1999, Human molecular genetics.

[70]  T. Zderic,et al.  Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[71]  A. Grace,et al.  The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis , 1995, Nature Medicine.

[72]  R. Kerber,et al.  Coronary arterial remodeling studied by high-frequency epicardial echocardiography: an early compensatory mechanism in patients with obstructive coronary atherosclerosis. , 1991, Journal of the American College of Cardiology.